Literature DB >> 22102226

X-ray structure of the SH3 domain of the phosphoinositide 3-kinase p85β subunit.

Shuai Chen1, Yibei Xiao, Rajesh Ponnusamy, Jinzhi Tan, Jian Lei, Rolf Hilgenfeld.   

Abstract

Src-homology 3 (SH3) domains are involved in extensive protein-protein interactions and constitute key elements of intracellular signal transduction. Three-dimensional structures have been reported for SH3 domains of various proteins, including the 85 kDa regulatory subunit (p85) of phosphoinositide 3-kinase. However, all of the latter structures are of p85 isoform α and no crystal structure of the SH3 domain of the equally important isoform β has been reported to date. In this structural communication, the recombinant production, crystallization and X-ray structure determination at 2.0 Å resolution of the SH3 domain of human p85β is described. The structure reveals a compact β-barrel fold very similar to that of p85α. However, binding studies with two classes of proline-rich ligand peptides demonstrate that the ligand-binding specificity differs slightly between the SH3 domains of human p85β and p85α, despite their high structural similarity.
© 2011 International Union of Crystallography. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22102226      PMCID: PMC3212445          DOI: 10.1107/S1744309111031691

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  25 in total

1.  Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses.

Authors:  Christina Ehrhardt; Thorsten Wolff; Stephan Pleschka; Oliver Planz; Wiebke Beermann; Johannes G Bode; Mirco Schmolke; Stephan Ludwig
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

2.  Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K.

Authors:  Yeun-Kyung Shin; Qiang Liu; Suresh K Tikoo; Lorne A Babiuk; Yan Zhou
Journal:  J Gen Virol       Date:  2007-01       Impact factor: 3.891

3.  Structure of the PI3K SH3 domain and analysis of the SH3 family.

Authors:  S Koyama; H Yu; D C Dalgarno; T B Shin; L D Zydowsky; S L Schreiber
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

4.  Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin.

Authors:  M E Noble; A Musacchio; M Saraste; S A Courtneidge; R K Wierenga
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

5.  Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase.

Authors:  G W Booker; I Gout; A K Downing; P C Driscoll; J Boyd; M D Waterfield; I D Campbell
Journal:  Cell       Date:  1993-05-21       Impact factor: 41.582

6.  Solution structure of the SH3 domain of phospholipase C-gamma.

Authors:  D Kohda; H Hatanaka; M Odaka; V Mandiyan; A Ullrich; J Schlessinger; F Inagaki
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

7.  SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation.

Authors:  Yeun-Kyung Shin; Yang Li; Qiang Liu; Deborah H Anderson; Lorne A Babiuk; Yan Zhou
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

8.  Structural studies of the phosphatidylinositol 3-kinase (PI3K) SH3 domain in complex with a peptide ligand: role of the anchor residue in ligand binding.

Authors:  Renu Batra-Safferling; Joachim Granzin; Susanne Mödder; Silke Hoffmann; Dieter Willbold
Journal:  Biol Chem       Date:  2010-01       Impact factor: 3.915

9.  Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries.

Authors:  R J Rickles; M C Botfield; Z Weng; J A Taylor; O M Green; J S Brugge; M J Zoller
Journal:  EMBO J       Date:  1994-12-01       Impact factor: 11.598

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.